Pricing Log in Create free account

Gelteq Limited (GELS) vs Sonoma Pharmaceuticals, Inc. (SNOA)

Gelteq Limited and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited and Sonoma Pharmaceuticals, Inc. are of similar size ($5.1M and $4.9M). Across the 9 metrics below, Gelteq Limited leads on 6 and Sonoma Pharmaceuticals, Inc. on 3.

Valuation

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — 0.19 2.08
P/B n/m 0.63 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 0.86 12.22
EV/Sales n/m (0.05) 2.87
Earnings yield — (112.96%) (15.94%)
Free cash flow yield 0.00% (63.92%) 0.00%

Profitability

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Gross margin — 38.91% 53.51%
Operating margin — (6.41%) 0.00%
Net margin — (10.33%) (2.45%)
Free cash flow margin 0.00% (12.11%) 0.00%
Return on equity 0.00% (42.52%) (0.80%)
Return on assets 0.00% (13.85%) (1.67%)
Return on invested capital 0.00% (69.96%) 0.00%

Growth

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 47.00% 5.22%
EPS growth (last fiscal year) (62.07%) 32.26% 42.91%
Revenue growth, 5-year CAGR — 0.95% 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.04
Current ratio 0.09 2.99 2.41
Net debt to EBITDA (0.91) 1.03 1.01

Dividend

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Market cap 4.88m 5.13m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack